Striatal μ-opioid receptor availability predicts cold pressor pain threshold in healthy human subjects

Neuroscience Letters

Volumn 521, Issue 1, 2012, Pages 11-14

  Hagelberg, Nora ^a,b   Aalto, Sargo ^b,c   Tuominen, Lauri ^b,d   Pesonen, Ullamari ^d   Någren, Kjell ^b,e   Hietala, Jarmo ^b,d   Scheinin, Harry ^b,d   Pertovaara, Antti ^f   Martikainen, Ilkka K ^d,g,h  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b TURKU PET CENTRE   (Finland)

^c ÅBO AKADEMI UNIVERSITY   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

^f UNIVERSITY OF HELSINKI   (Finland)

^g TAMPERE UNIVERSITY HOSPITAL   (Finland)

^h UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Opioid receptor; 11C carfentanil; Pain; Positron emission tomography; Striatum

Indexed keywords

CARBON 11; CARFENTANIL; MU OPIATE RECEPTOR;

ADULT; ARTICLE; BRAIN REGION; COLD PRESSOR TEST; CORPUS STRIATUM; HUMAN; HUMAN EXPERIMENT; MALE; NOCICEPTION; NORMAL HUMAN; PAIN THRESHOLD; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BINDING; SOMATOSENSORY STIMULATION; TACTILE STIMULATION;

ADULT; CARBON RADIOISOTOPES; COLD TEMPERATURE; CORPUS STRIATUM; FENTANYL; HUMANS; MALE; PAIN; PAIN THRESHOLD; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTORS, OPIOID, MU; REFERENCE VALUES; TOUCH;

EID: 84862628005     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.05.042     Document Type: Article

References (22)

1. 11C]-carfentanil and positron emission tomography (PET). Pain 2002, 99:589-598.
2. Casey K.L., Svensson P., Morrow T.J., Raz J., Jone C., Minoshima S. Selective opiate modulation of nociceptive processing in the human brain. J. Neurophysiol. 2000, 84:525-533.
3. Cleeland C.S., Nakamura Y., Howland E.W., Morgan N.R., Edwards K.R., Backonja M. Effects of oral morphine on cold pressor tolerance time and neuropsychological performance. Neuropsychopharmacology 1996, 15:252-262.
4. Comer S.D., Cooper Z.D., Kowalczyk W.J., Sullivan M.A., Evans S.M., Bisaga A.M., Vosburg S.K. Evaluation of potential sex differences in the subjective and analgesic effects of morphine in normal and healthy volunteers. Psychopharmacology (Berl.) 2010, 208:45-55.
5. Gear R.W., Levine J.D. Antinociception produced by an ascending spino-supraspinal pathway. J. Neurosci. 1995, 15:3154-3161.
6. Gear R.W., Levine J.D. Nucleus accumbens facilitates nociception. Exp. Neurol. 2011, 229:502-506.
7. Harris R.E., Clauw D.J., Scott D.J., McLean S.A., Gracely R.H., Zubieta J.K. Decreased central mu-opioid receptor availability in fibromyalgia. J. Neurosci. 2007, 27:10000-10006.
8. Harris R.E., Zubieta J.K., Scott D.J., Napadow V., Gracely R.H., Clauw D.J. Traditional Chinese acupuncture and placebo (sham) acupuncture are differentiated by their effects on mu-opioid receptors (MORs). Neuroimage 2009, 47:1077-1085.
9. 11C]carfentanil: a test-retest study in healthy subjects. Eur. J. Nucl. Med. Mol. Imaging 2009, 36:275-286.
10. Innis R.B., Cunningham V.J., Delforge J., Fujita M., Gjedde A., Gunn R.N., Holden J., Houle S., Huang S.C., Ichise M., Iida H., Ito H., Kimura Y., Koeppe R.A., Knudsen G.M., Knuuti J., Lammertsma A.A., Laruelle M., Logan J., Maguire R.P., Mintun M.A., Morris E.D., Parsey R., Price J.C., Slifstein M., Sossi V., Suhara T., Votaw J.R., Wong D.F., Carson R.E. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J. Cereb. Blood Flow Metab. 2007, 27:1533-1539.
11. Jarvik L.F., Simpson J.H., Guthrie D., Liston E.H. Morphine, experimental pain, and psychological reactions. Psychopharmacology (Berl.) 1981, 75:124-131.
12. Jones S.F., McQuay H.J., Moore R.A., Hand C.W. Morphine and ibuprofen compared using the cold pressor test. Pain 1988, 34:117-122.
13. Lammertsma A.A., Hume S.P. Simplified reference tissue model for PET receptor studies. Neuroimage 1996, 4:153-158.
14. 11C]MADAM: a test-retest reproducibility study. Synapse 2006, 60:256-263.
15. Martikainen I.K., Hagelberg N., Mansikka H., Hietala J., Någren K., Scheinin H., Pertovaara A. Association of striatal dopamine D2/D3 receptor binding potential with pain but not tactile sensitivity or placebo analgesia. Neurosci. Lett. 2005, 376:149-153.
16. Rainville P., Feine J.S., Bushnell M.C., Duncan G.H. A psychophysical comparison of sensory and affective responses to four modalities of experimental pain. Somatosens. Mot. Res. 1992, 9:265-277.
17. Ray R., Ruparel K., Newberg A., Wileyto E.P., Loughead J.W., Divgi C., Blendy J.A., Logan J., Zubieta J.K., Lerman C. Human mu opioid receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:9268-9273.
18. Ribeiro S.C., Kennedy S.E., Smith Y.R., Stohler C.S., Zubieta J.K. Interface of physical and emotional stress regulation through the endogenous opioid system and mu-opioid receptors. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29:1264-1280.
19. Zubieta J.K., Bueller J.A., Jackson L.R., Scott D.J., Xu Y., Koeppe R.A., Nichols T.E., Stohler C.S. Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J. Neurosci. 2005, 25:7754-7762.
20. Zubieta J.K., Dannals R.F., Frost J.J. Gender and age influences on human brain mu-opioid receptor binding measured by PET. Am. J. Psychiatry 1999, 156:842-848.
21. Zubieta J.K., Ketter T.A., Bueller J.A., Xu Y., Kilbourn M.R., Young E.A., Koeppe R.A. Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission. Arch. Gen. Psychiatry 2003, 60:1145-1153.
22. Zubieta J.K., Smith Y.R., Bueller J.A., Xu Y., Kilbourn M.R., Jewett D.M., Meyer C.R., Koeppe R.A., Stohler C.S. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 2001, 293:311-315.